Cicatrix Completed Phase 2 Trials for Estradiol (DB00783)

IndicationStatusPhase
DBCOND0036402 (Cicatrix)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00984386Investigation of the Efficacy of Zesteem in Accelerating Early Wound HealingTreatment